The Effect of Age and Recent Influenza Vaccination History on the Immunogenicity and Efficacy of 2009-10 Seasonal Trivalent Inactivated Influenza Vaccination in Children

被引:36
|
作者
Ng, Sophia [1 ]
Ip, Dennis K. M. [1 ]
Fang, Vicky J. [1 ]
Chan, Kwok-Hung [2 ]
Chiu, Susan S. [3 ]
Leung, Gabriel M. [1 ]
Peiris, J. S. Malik [1 ,4 ]
Cowling, Benjamin J. [1 ]
机构
[1] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China
[2] Univ Hong Kong, Li Ka Shing Fac Med, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China
[3] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China
[4] Univ Hong Kong, Li Ka Shing Fac Med, Influenza Res Ctr, Hong Kong, Hong Kong, Peoples R China
来源
PLOS ONE | 2013年 / 8卷 / 03期
关键词
ANTIBODY-RESPONSES; PANDEMIC INFLUENZA; PROTECTIVE EFFICACY; ANNUAL IMMUNIZATION; IMMUNE-RESPONSE; VIRUS; STRAINS; YOUNG; VACCINES;
D O I
10.1371/journal.pone.0059077
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: There is some evidence that annual vaccination of trivalent inactivated influenza vaccine (TIV) may lead to reduced vaccine immunogenicity but evidence is lacking on whether vaccine efficacy is affected by prior vaccination history. The efficacy of one dose of TIV in children 6-8 y of age against influenza B is uncertain. We examined whether immunogenicity and efficacy of influenza vaccination in school-age children varied by age and past vaccination history. Methods and Findings: We conducted a randomized controlled trial of 2009-10 TIV. Influenza vaccination history in the two preceding years was recorded. Immunogenicity was assessed by comparison of HI titers before and one month after receipt of TIV/placebo. Subjects were followed up for 11 months with symptom diaries, and respiratory specimens were collected during acute respiratory illnesses to permit confirmation of influenza virus infections. We found that previous vaccination was associated with reduced antibody responses to TIV against seasonal A(H1N1) and A(H3N2) particularly in children 9-17 y of age, but increased antibody responses to the same lineage of influenza B virus in children 6-8 y of age. Serological responses to the influenza A vaccine viruses were high regardless of vaccination history. One dose of TIV appeared to be efficacious against confirmed influenza B in children 6-8 y of age regardless of vaccination history. Conclusions: Prior vaccination was associated with lower antibody titer rises following vaccination against seasonal influenza A vaccine viruses, but higher responses to influenza B among individuals primed with viruses from the same lineage in preceding years. In a year in which influenza B virus predominated, no impact of prior vaccination history was observed on vaccine efficacy against influenza B. The strains that circulated in the year of study did not allow us to study the effect of prior vaccination on vaccine efficacy against influenza A.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Immunogenicity of influenza vaccination in children with Inflammatory Bowel Disease
    deBruyn, J.
    Hilsden, R.
    Wrobel, I
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (12) : S3 - S3
  • [22] Prevalence of Influenza-Like Illness and Seasonal and Pandemic H1N1 Influenza Vaccination Coverage Among Workers - United States, 2009-10 Influenza Season
    Luckhaupt, Sara E.
    Calvert, Geoffrey M.
    Li, Jia
    Sweeney, Marie
    Santibanez, Tammy A.
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2014, 63 (10): : 217 - 221
  • [23] Simple models to include influenza vaccination history when evaluating the effect of influenza vaccination
    Martinez-Baz, Ivan
    Navascues, Ana
    Casado, Itzlar
    Aguinaga, Altzlber
    Ezpeleta, Carmen
    Castilla, Jesus
    EUROSURVEILLANCE, 2021, 26 (32)
  • [24] Multivariate analysis of factors affecting the immunogenicity of trivalent inactivated influenza vaccine in school-age children
    Freeman, G.
    Ng, S.
    Perera, R. A. P. M.
    Fang, V. J.
    Ip, D. K. M.
    Leung, G. M.
    Peiris, J. S. M.
    Cowling, B. J.
    EPIDEMIOLOGY AND INFECTION, 2015, 143 (03): : 540 - 549
  • [25] Immunogenicity and Safety of Inactivated Quadrivalent and Trivalent Influenza Vaccines in Children 18-47 Months of Age
    Rodriguez Weber, Miguel A.
    Claeys, Carine
    Aranza Doniz, Carlos
    Feng, Yang
    Innis, Bruce L.
    Jain, Varsha K.
    Peeters, Mathieu
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2014, 33 (12) : 1262 - 1269
  • [26] A randomized controlled study to evaluate the immunogenicity of a trivalent inactivated seasonal influenza vaccine at two dosages in children 6 to 35 month of age
    Pavia-Ruz, Noris
    Rodriguez Weber, Miguel Angel
    Lau, Yu-Lung
    Nelson, E. Anthony S.
    Kerdpanich, Angkool
    Huang, Li-Min
    Silas, Peter
    Qaqundah, Paul
    Blatter, Mark
    Jeanfreau, Robert
    Lei, Paul
    Jain, Varsha
    El Idrissi, Mohamed
    Feng, Yang
    Innis, Bruce
    Peeters, Mathieu
    Devaster, Jeanne-Marie
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2013, 9 (09) : 1978 - 1988
  • [27] Efficacy and safety of influenza vaccination in children with asthma
    Patria, Maria Francesca
    Tenconi, Rossana
    Esposito, Susanna
    EXPERT REVIEW OF VACCINES, 2012, 11 (04) : 461 - 468
  • [28] Influenza vaccination in children: Inactivated vaccines or live attenuated vaccines?
    Brouard, J.
    Tran, L.
    Flammang, A.
    Dupont, C.
    Vabret, A.
    ARCHIVES DE PEDIATRIE, 2017, 24 (03): : 211 - 214
  • [29] Immunogenicity, safety and tolerability of inactivated trivalent influenza vaccine in overweight and obese children
    Esposito, Susanna
    Giavoli, Claudia
    Trombetta, Claudia
    Bianchini, Sonia
    Montinaro, Valentina
    Spada, Anna
    Montomoli, Emanuele
    Principi, Nicola
    VACCINE, 2016, 34 (01) : 56 - 60
  • [30] Modelling the effect of seasonal influenza vaccination on the risk of pandemic influenza infection
    Mercer, Geoffry N.
    Barry, Steven I.
    Kelly, Heath
    BMC PUBLIC HEALTH, 2011, 11